How long should immune checkpoint inhibitor therapy be used in non-small cell lung cancer?
Hospital Pharmacy Europe
JULY 17, 2023
Immune checkpoint inhibitors have transformed the management of non-small cell lung cancer, but how long should treatment be continued for optimal survival? It has long been recognised that a hallmark of cancer is immune evasion and that the immune system is held back by inhibitory immune checkpoint receptors and ligands.
Let's personalize your content